第一作者:
Sunil,Bhandari
第一单位:
From the Department of Renal Medicine, Hull University Teaching Hospitals NHS Trust, and Hull York Medical School, Hull (S.B.), the Birmingham Clinical Trials Unit, Institute of Applied Health Research (S.M., N.I., E.B., M.C.), and the Institute of Inflammation and Aging (P.C.), University of Birmingham, and the Department of Renal Medicine, Queen Elizabeth Hospital, University Hospitals Birmingham (P.C.), Birmingham, the Sheffield Kidney Institute, Sheffield (A.K.), and the British Heart Foundation Centre for Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow (J.G.F.C.) - all in the United Kingdom.
作者:
医学主题词
人类(Humans);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);血管紧张素类(Angiotensins);抗高血压药(Antihypertensive Agents);肾小球滤过率(Glomerular Filtration Rate);肾功能衰竭, 慢性(Kidney Failure, Chronic);生活质量(Quality of Life);肾功能不全, 慢性(Renal Insufficiency, Chronic);肾素-血管紧张素系统(Renin-Angiotensin System)
DOI
10.1056/NEJMoa2210639
PMID
36326117
发布时间
2025-05-30
- 浏览1
The New England journal of medicine
2021-2032页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



